LAV overview
LAV related stories
SFERS approves $230m in commitments
The US public pension has backed multi-regional focused private equity funds.
LACERA approves $100m commitment to LAV Biosciences Fund V
The US public pension has backed an Asia-Pacific biomedical growth fund.
LAV contact information
Offices
Room 2909-17, 168 Hubin Road, Huangpu District, Shanghai, , ChinaContacts
| Name | Job title | Location | |
|---|---|---|---|
 Mr. Andiely Lu | Job titleVice President, Healthcare Investments | LocationShanghai, China | Email  ------- |
| Mr. Cong Xu | Job titleManaging Director | LocationShanghai, China | Email ------- |
| Mr. Dezhi Kang | Job titlePrincipal, Biotech and Healthcare Investment | LocationMenlo Park, United States | Email --------- |
| Mr. Fei Chen | Job titleManaging Partner | LocationShanghai, China | Email ----------- |
LAV funds managed
Closed funds: 9
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size --------- | Close dateMay 2025 | Strategy ----- | |
| ------- | Fund size ----- | Close dateFeb 2021 | Strategy -------- |
| ------ | Fund size -------- | Close dateJan 2021 | Strategy ----- |